The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The American Cancer Society said one in eight men will be ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

The University of Mississippi Medical Center Cancer Center and Research Institute received a $1.4 million grant from the U.S.

We conducted a narrative review of clinical trials focused on GU malignancy (prostate ... assess treatment burden across key domains including financial, time and travel, and medication management.

Postmenopausal Hormone Replacement Therapy and Breast Cancer. MedGenMed 2(4), 2000. [formerly published in Medscape Women's Health eJournal 5(4), 2000]. Available at: https://www.medscape.com ...

Compared to white men, Black men are at greater risk of prostate cancer, more likely to develop it earlier, and more likely to die from it. Earlier screening may be warranted. Dr. Sheel Patel ...

Treatment for lung cancer varies according to age, type of cancer, extent of disease, tolerance to medication and patient preference. Treatment options include a combination of surgery, radiation, ...